Innospec (NASDAQ:IOSP) Sets New 1-Year Low – What’s Next?

Innospec Inc. (NASDAQ:IOSP)’s stock price hit a new 52-week low during mid-day trading on Wednesday . The company traded as low as $102.29 and last traded at $101.55, with a volume of 8113 shares traded. The stock had previously closed at $109.88.

Analyst Ratings Changes

Separately, StockNews.com downgraded shares of Innospec from a “strong-buy” rating to a “buy” rating in a research note on Saturday, January 11th.

Innospec Price Performance

The stock has a market cap of $2.58 billion, a price-to-earnings ratio of 72.86 and a beta of 1.09. The firm’s 50-day moving average is $111.12 and its 200 day moving average is $112.52.

Innospec (NASDAQ:IOSP) last announced its quarterly earnings data on Tuesday, February 18th. The specialty chemicals company reported $1.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.05. The company had revenue of $466.80 million during the quarter, compared to analysts’ expectations of $447.43 million. Innospec had a net margin of 1.93% and a return on equity of 12.27%. On average, sell-side analysts forecast that Innospec Inc. will post 6.18 EPS for the current year.

Hedge Funds Weigh In On Innospec

Large investors have recently modified their holdings of the company. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in shares of Innospec by 16.8% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 89,018 shares of the specialty chemicals company’s stock worth $9,797,000 after purchasing an additional 12,825 shares during the period. Westwood Holdings Group Inc. grew its stake in Innospec by 1.1% during the fourth quarter. Westwood Holdings Group Inc. now owns 298,096 shares of the specialty chemicals company’s stock worth $32,808,000 after buying an additional 3,352 shares during the period. Two Sigma Advisers LP increased its position in shares of Innospec by 48.5% in the fourth quarter. Two Sigma Advisers LP now owns 10,100 shares of the specialty chemicals company’s stock worth $1,112,000 after acquiring an additional 3,300 shares in the last quarter. State of Wyoming raised its stake in shares of Innospec by 167.0% in the 4th quarter. State of Wyoming now owns 1,976 shares of the specialty chemicals company’s stock valued at $217,000 after acquiring an additional 1,236 shares during the period. Finally, Point72 Asset Management L.P. lifted its holdings in shares of Innospec by 27.6% during the 4th quarter. Point72 Asset Management L.P. now owns 2,425 shares of the specialty chemicals company’s stock valued at $267,000 after acquiring an additional 525 shares in the last quarter. 96.64% of the stock is currently owned by hedge funds and other institutional investors.

Innospec Company Profile

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.